This playbook explores key strategies for overcoming challenges in drug-device combination product development, ensuring quality, scalability, and successful market entry.
The drug-device combination (DDC) market is expanding rapidly, driven by patient demand for safer, more convenient therapies. But developing and manufacturing these products is complex, requiring careful planning, regulatory expertise, and scalable production strategies.
In Optimizing Drug-Device Combination Product Manufacturing: A Clinical to Commercial Roadmap, we explore the six critical challenges that DDC producers face, and how to overcome them with the right CDMO partnership.
This playbook covers:
- Scaling production – Learn how to align clinical and commercial goals to ensure seamless manufacturing.
- Navigating regulatory complexity – Get insights into human factors studies, compliance requirements, and market approvals.
- Managing risk and efficiency in supply chains – Discover how strategic supply chain planning minimizes delays and reduces waste.
- Accelerating time-to-market – Find out how early device integration can speed up approvals and commercialization.
Offered Free by: BioPharma Dive’s studioID and PCI Pharma Services
See All Resources from: BioPharma Dive’s studioID and PCI Pharma Services
